Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Humphrey

Showing results (311-320 of 325) with videos related to

Pageof 33
Sort By:
BMJ Open|April 30, 2025
Cohort profile: measuring adverse pregnancy and newborn congenital outcomes (MANGO) study in KenyaJohn M Humphrey, Audrey Chepkemoi, Steven Brown, et al.
Birth Defects Research|February 2, 2026
Human-Centered Design of a Contextualized Service Delivery Model for Families of Infants With Major Congenital Anomalies in KenyaAudrey Chepkemoi, Molly McPheron, Violet Naanyu, et al.
Journal of Medicinal Chemistry|May 9, 2013
Design and selection parameters to accelerate the discovery of novel central nervous system positron emission tomography (PET) ligands and their application in the development of a novel phosphodiesterase 2A PET ligandLei Zhang, Anabella Villalobos, Elizabeth M Beck, et al.
Bioorganic & Medicinal Chemistry Letters|January 14, 2015
Discovery of indole-derived pyridopyrazine-1,6-dione γ-secretase modulators that target presenilinMartin Pettersson, Douglas S Johnson, John M Humphrey, et al.
Annals of Internal Medicine|November 29, 2021
Disparities in Dolutegravir Uptake Affecting Females of Reproductive Age With HIV in Low- and Middle-Income Countries After Initial Concerns About Teratogenicity : An Observational StudyMatthew L Romo, Rena C Patel, Jessie K Edwards, et al.
Journal of Medicinal Chemistry|June 10, 2011
Use of structure-based design to discover a potent, selective, in vivo active phosphodiesterase 10A inhibitor lead series for the treatment of schizophreniaChristopher J Helal, Zhijun Kang, Xinjun Hou, et al.
Brain : a Journal of Neurology|September 22, 2018
A feedback loop between dipeptide-repeat protein, TDP-43 and karyopherin-α mediates C9orf72-related neurodegenerationDaniel A Solomon, Alan Stepto, Wing Hei Au, et al.
Journal of Medicinal Chemistry|September 29, 2017
The Discovery of a Novel Phosphodiesterase (PDE) 4B-Preferring Radioligand for Positron Emission Tomography (PET) ImagingLei Zhang, Laigao Chen, Elizabeth M Beck, et al.
Cell Chemical Biology|September 30, 2020
Photoaffinity Labeling and Quantitative Chemical Proteomics Identify LXRβ as the Functional Target of Enhancers of Astrocytic apoEUthpala Seneviratne, Zhen Huang, Christopher W Am Ende, et al.
Medchemcomm|August 16, 2018
Discovery of cyclopropyl chromane-derived pyridopyrazine-1,6-dione γ-secretase modulators with robust central efficacyMartin Pettersson, Douglas S Johnson, Danica A Rankic, et al.
Pageof 33

Showing results (311-320 of 325) with videos related to

Sort By:
Pageof 33
BMJ Open|April 30, 2025
Cohort profile: measuring adverse pregnancy and newborn congenital outcomes (MANGO) study in KenyaJohn M Humphrey, Audrey Chepkemoi, Steven Brown, et al.
Birth Defects Research|February 2, 2026
Human-Centered Design of a Contextualized Service Delivery Model for Families of Infants With Major Congenital Anomalies in KenyaAudrey Chepkemoi, Molly McPheron, Violet Naanyu, et al.
Journal of Medicinal Chemistry|May 9, 2013
Design and selection parameters to accelerate the discovery of novel central nervous system positron emission tomography (PET) ligands and their application in the development of a novel phosphodiesterase 2A PET ligandLei Zhang, Anabella Villalobos, Elizabeth M Beck, et al.
Bioorganic & Medicinal Chemistry Letters|January 14, 2015
Discovery of indole-derived pyridopyrazine-1,6-dione γ-secretase modulators that target presenilinMartin Pettersson, Douglas S Johnson, John M Humphrey, et al.
Annals of Internal Medicine|November 29, 2021
Disparities in Dolutegravir Uptake Affecting Females of Reproductive Age With HIV in Low- and Middle-Income Countries After Initial Concerns About Teratogenicity : An Observational StudyMatthew L Romo, Rena C Patel, Jessie K Edwards, et al.
Journal of Medicinal Chemistry|June 10, 2011
Use of structure-based design to discover a potent, selective, in vivo active phosphodiesterase 10A inhibitor lead series for the treatment of schizophreniaChristopher J Helal, Zhijun Kang, Xinjun Hou, et al.
Brain : a Journal of Neurology|September 22, 2018
A feedback loop between dipeptide-repeat protein, TDP-43 and karyopherin-α mediates C9orf72-related neurodegenerationDaniel A Solomon, Alan Stepto, Wing Hei Au, et al.
Journal of Medicinal Chemistry|September 29, 2017
The Discovery of a Novel Phosphodiesterase (PDE) 4B-Preferring Radioligand for Positron Emission Tomography (PET) ImagingLei Zhang, Laigao Chen, Elizabeth M Beck, et al.
Cell Chemical Biology|September 30, 2020
Photoaffinity Labeling and Quantitative Chemical Proteomics Identify LXRβ as the Functional Target of Enhancers of Astrocytic apoEUthpala Seneviratne, Zhen Huang, Christopher W Am Ende, et al.
Medchemcomm|August 16, 2018
Discovery of cyclopropyl chromane-derived pyridopyrazine-1,6-dione γ-secretase modulators with robust central efficacyMartin Pettersson, Douglas S Johnson, Danica A Rankic, et al.
Pageof 33